“…This suggests an epidemiological link to the Arabian Gulf, as previously also assumed for other MRSA. 35 rRNA adenine N-6-methyltransferase macrolide-lincosamide-streptogramin B resistance protein 11,34 11,34 aacA-aphD Bifunctional enzyme Aac/Aph, 6 0 -aminoglycoside Nacetyltransferase/2 00 -aminoglycoside phosphotransferase; gentamicin and tobramycin resistance 11,34 11,34 aadD Aminoglycoside adenyltransferase, tobramycin resistance 11,34 11,34 dfrA Dihydrofolate reductase, mediates trimethoprim resistance 11,34 11,34 lukF/S-PV Panton-Valentine leukocidin 11,34 11,34 tst1 Toxic shock syndrome toxin 11,34 11,34 sec+sel Enterotoxins C and L 11,34 11,34 egc cluster Enterotoxin gene cluster (comprising seg, sei sem, sen, seo, seu) 11,34 11,34 sak, chp, scn Staphylokinase, chemotaxis-inhibiting protein, staphyl. complement inhibitor 11,34 11,34 eta, etb, etd Exfoliative toxins 11,34 11,34 ACME Arginine catabolic mobile element 11,34 11,34 fnbB Fibronectin binding protein B, variably detected in CC22 because it is in some strains fused with fnbA 11, 34 11,34 cna, sasG Collagen adhesin; Staphylococcus aureus surface protein G (present in CC22) 11,34 11,34 In conclusion, 'true' UK-EMRSA-15/Barnim EMRSA was not identified from KSA, with all tested CC22-MRSA-IV differing either in toxin carriage and/or in SCCmec subtype.…”